Skip to Main Content

Paper Details

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial.
Eur Heart J
107
2018
Author NameAffiliation
Charles V PollackThomas Jefferson University
  • 1 - 1

Datasets

Release 1.2